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Summary
Background: Synaptic transmission can occur in a binary or
graded fashion, depending on whether transmitter release is
triggered by action potentials or by gradual changes in
membrane potential. Molecular differences of these two types
of fusion events and their differential regulation in a physiolog-
ical context have yet to be addressed. Complexin is a
conserved SNARE-binding protein that has been proposed
to regulate both spontaneous and stimulus-evoked synaptic
vesicle (SV) fusion.
Results: Here we examine complexin function at a graded
synapse in C. elegans. Null complexin (cpx-1) mutants are
viable, although nervous system function is significantly
impaired. Loss of CPX-1 results in a 3-fold increase in the
rate of tonic synaptic transmission at the neuromuscular junc-
tion, whereas stimulus-evoked SV fusion is decreased 10-fold.
A truncated CPX-1 missing its C-terminal domain can rescue
stimulus-evoked synaptic vesicle exocytosis but fails to
suppress tonic activity, demonstrating that these two modes
of exocytosis can be distinguished at the molecular level. A
CPX-1 variant with impaired SNARE binding also rescues
evoked, but not tonic, neurotransmitter release. Finally, tonic,
but not evoked, release can be rescued in a syntaxin point
mutant by removing CPX-1. Rescue of either form of exocy-
tosis partially restores locomotory behavior, indicating that
both types of synaptic transmission are relevant.
Conclusion: These observations suggest a dual role for
CPX-1: suppressing SV exocytosis, driven by low levels of
endogenous neural activity, while promoting synchronous
fusion of SVs driven by a depolarizing stimulus. Thus, patterns
of synaptic activity regulate complexin’s inhibitory and permis-
sive roles at a graded synapse.
Introduction
Neurotransmitter release is predominantly driven by action
potentials in the vertebrate nervous system, whereas graded
neurotransmission is typically observed at sensory synapses
and at dendrodendritic connections [1–4]. Invertebrate
nervous systems display both impulse-driven and graded
synaptic transmission, sometimes at the same synapse [5–7].
It is widely thought that the underlying mechanism of synaptic
vesicle (SV) exocytosis is identical in these two forms of
signaling, although the molecular differences have yet to be*Correspondence: jed2019@med.cornell.edu
3These authors contributed equally to this workexplored. Synaptic transmission is initiated by the fusion of
a synaptic vesicle with the presynaptic membrane, a highly
regulated process involving a host of specialized presynaptic
proteins [8–10]. SV fusion is catalyzed by the assembly of
a four-helix bundle containing three major SNARE proteins:
synaptobrevin, SNAP-25, and syntaxin. The detailedmolecular
chainof eventsprogressing fromSNAREassembly toSV fusion
is not fully understood, but several SNARE-binding proteins
have been proposed to regulate this sequence [10, 11].
In particular, the protein complexin has garneredmuch interest
because of its ability to bind to the assembled ternary SNARE
complex with high affinity. Complexin is a 15–18 kDa cyto-
plasmic protein that contains a central a-helical region that
binds within the groove between synaptobrevin and syntaxin
in the assembled SNARE complex [12–16]. How the binding
of complexin to the SNARE complex regulates the probability
of SV fusion is controversial.
In vitro studies using SNARE-mediated fusion of proteolipo-
somes or cell-cell fusion have suggested that complexin either
inhibits [17–19] or stimulates [20, 21] fusion. In several synaptic
preparations, complexin function was explored in the context
of two types of SV exocytosis events: action potential-trig-
gered fusion initiated by a depolarizing stimulus (evoked
release) and stochastic fusion eventsmonitored in the absence
of activity (spontaneous release). Neuronal cultures and brain
slices derived from complexin knockout mice exhibited
a reduction in evoked neurotransmitter release, as well as
decreased spontaneous fusion events [22–25]. In contrast,
complexin knockdown by RNA interference led to elevated
spontaneous release in conjunction with decreased evoked
release [26]. Genetic deletion of complexin inDrosophila mela-
nogaster also increased tonic fusion at the neuromuscular
junction (NMJ) while simultaneously reducing evoked release
[27, 28]. Cross-species rescue experiments and chimeric
variants of complexin demonstrated that mouse and fly com-
plexins share domains that can both enhance and inhibit
exocytosis, indicating that complexin is a multifunctional
protein and possibly has multiple duties at the synapse [25].
In this study, we investigated the consequences of removing
the complexin ortholog CPX-1 on neurotransmission in
C. elegans. We provide evidence that CPX-1 inhibits the
continuous release of neurotransmitter driven by low levels
of endogenous neural activity (tonic release). In contrast,
CPX-1 is required for SV fusion evoked by a depolarizing stim-
ulus electrode. Both of these modes of synaptic transmission
are shown to be behaviorally relevant. Each mode of exocy-
tosis could be independently rescued, suggesting that com-
plexin operates through distinct mechanisms during synaptic
transmission. Thus, CPX-1 can function to regulate synaptic
transmission in an activity-dependent manner. A detailed
understanding of complexin’s role may help delineate the
molecular mechanisms underlying SV exocytosis.
Results
Mutants Lacking CPX-1 Have Motor System Defects
The C. elegans genome contains two complexin homologs:
cpx-1 and cpx-2. Of these two genes, cpx-1 shares a higher
Figure 1. cpx-1 Mutants Display Motor System
Defects
(A) Protein sequence alignment for C. elegans
CPX-1 (worm), D. melanogaster dmCplx Gen-
Bank AAF69518.1 (fly), andmouse Cplx1 (mouse)
using a ClustalW algorithm. The N-terminal
domain (NTD), accessory domain (AD), central
helix (CH), and C-terminal domain (CTD) are indi-
cated in gray. Identically conserved residues
across all three species are shaded in red,
whereas similar residues are shaded in blue.
(B) Percent sequence identity for each domain is
indicated for each pairwise comparison: worm
(w), fly (f), and mouse (m).
(C) Representative trajectories for 20 animals
for wild-type, cpx-1(ok1552), cpx-1 expressing
a rescuing cDNA under a GABA promoter, and
cpx-1 expressing a rescuing cDNA in all neurons.
(D) Summary of average speed for the four
strains. The number of animals measured for
each average is indicated within the bar.
(E) Paralysis time course on 1.0 mM aldicarb for
wild-type (black circles), cpx-1 (red triangles),
rescue in GABA neurons (open green squares),
and rescue in all neurons (open blue circles).
Data are mean 6 standard error of the mean
(SEM). # denotes significantly different from
wild-type (p < 0.01) but not significantly different
from cpx-1. ** denotes significantly different from
cpx-1 (p < 0.01) but not significantly different from
wild-type. Significance determined by Tukey-
Kramer method.
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98degree of homology with themouse (32% versus 19% identity)
and fly (44% versus 28% identity) complexins (Figure 1A). The
protein structure and function of mouse complexin suggests
that it possesses four domains, with the central helix (CH)
domain displaying the highest degree of conservation. The
worm complexin protein CPX-1 contains a CH domain
with 78% identity to the mouse Cplx1 and 91% identity to
the Drosophila complexin dmCplx (Figure 1B). In order to
study the role of complexin in the worm nervous system, we
utilized the mutant cpx-1(ok1552), which carries a 1.3 kb dele-
tion of the cpx-1 gene, removing one of its two exons. cpx-1
(ok1552) animals are viable but have significant defects in
locomotion, whereas heterozygous animals are indistinguish-
able from wild-type. We also examined cpx-2 mutants, and,
based on expression data and behavioral studies, we found
that CPX-2 does not function redundantly with CPX-1 (see Fig-
ure S1 available online). We thus focused on CPX-1 as the
major complexin in C. elegans.
We quantified the decrease in locomotion of cpx-1 mutants
by recording the center-of-mass speed of individual animals
moving on an agar plate (Figure 1C). Compared to wild-type
controls, cpx-1 mutants moved at significantly slower speeds
(40% 6 2.2% of wild-type), consistent with a nervous systemdefect (Figure 1D). We cloned the full-
length cDNA encoding CPX-1 and
expressed a CPX-1::GFP fusion protein
under a neuronal promoter (snb-1 syn-
aptobrevin) in cpx-1 mutants. CPX-
1::GFP restored locomotion (104% 6
5.7% of wild-type), confirming that the
locomotion defect was specific to loss
of complexin in the nervous system
(Figure 1D).We also examined the sensitivity of cpx-1 mutants to aldi-
carb, a cholinesterase inhibitor. Acetylcholine (ACh) levels in
the NMJ are rapidly reduced through the enzymatic action
of acetylcholinesterases, and inhibition of these enzymes
results in a buildup of ACh, followed by paralysis of the animal
[29]. Animals with defects in ACh secretion are resistant to
aldicarb, whereas animals secreting higher than normal levels
of ACh are hypersensitive and quickly paralyze upon expo-
sure to aldicarb [30–32]. We examined the time course of
paralysis on 1.0 mM aldicarb for wild-type and cpx-1 mutant
animals (Figure 1E). cpx-1 mutants were paralyzed within
20 min of aldicarb exposure, whereas wild-type animals
required 2 hr to paralyze. Neuronal expression of CPX-
1::GFP completely restored normal aldicarb sensitivity, sug-
gesting that CPX-1 normally inhibits the secretion of ACh.
Alternatively, if CPX-1 specifically acts in GABA motor
neurons to promote release, decreased GABA release in the
cpx-1 mutant could also account for its hypersensitivity to
aldicarb [33]. To test this hypothesis, we attempted to rescue
cpx-1 mutants with CPX-1::GFP under a GABA-specific
promoter (unc-25 GAD). Neither locomotion nor aldicarb
sensitivity were altered (Figures 1D and 1E), suggesting that
defects in GABA neuron function in cpx-1 mutants cannot
Figure 2. CPX-1 Is Expressed throughout the Nervous
System and Localizes to Synapses
(A1) Fluorescent image of the head region expressing
GFP under the cpx-1 promoter.
(A2) Expression of GFP under the cpx-1 promoter in the
body region. Note the cell bodies in the ventral nerve
cord at the top with commissural fibers extending to
the dorsal nerve cord.
(B1) Expression ofmCherry under a cholinergic promoter
(unc-17 VAChT) and a nuclear-localized GFP under the
cpx-1 promoter in the ventral nerve cord.
(B2) Expanded view of the inset in (B1) showing indi-
vidual cholinergic (white arrows) and GABAergic (blue
arrowheads) motor neurons expressing cpx-1.
(C1 and C2) Fluorescent images of the dorsal nerve cord
expressing a CPX-1::GFP fusion protein (C1) andmCher-
ry::Rab3 (C2).
(C3) The two fluorescent images merged and color
coded.
Scale bars are 25 mm in (A1) and (A2), 30 mm in (B1), 10 mm
in (B2), and 5 mm in (C1)–(C3).
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99account for the observed behavioral phenotypes. Consistent
with a role for CPX-1 in ACh release, we found that rescue
of CPX-1::GFP under a cholinergic promoter (unc-17 VAChT)
nearly completely rescued wild-type aldicarb sensitivity
(Figure S2A).
CPX-1 Is a Synaptic Protein Broadly Expressed
in the Nervous System
To examine the expression of cpx-1 in C. elegans, we drove
expression of GFP under the control of the cpx-1 promoter
(3 kb upstream region). Expression was observed in a large
number of neurons in the head, ventral cord, and tail, including
all cholinergic and GABAergic motor neurons in the ventral
cord (Figures 2A and 2B). In contrast, cpx-2 is expressed in
only a small number of neurons having little or no overlap
with cpx-1 expression (Figure S1B). To examine the subcel-
lular localization of CPX-1, we imaged CPX-1::GFP in the
dorsal nerve cord under the control of a modified unc-129
promoter, which expresses in a subset of DA and DB cholin-
ergicmotor neurons [34]. CPX-1::GFPwas diffusely expressed
throughout the axon with some enrichment at presynaptic
terminals based on colocalization with an SVmarker mCherry::
Rab-3 (Figure 2C).
Tonic Activity Is Elevated, and Evoked Release
Is Decreased, in the Absence of Complexin
The behavioral assays and expression pattern indicate that
CPX-1 plays a major role in the nervous system. To examine
the effects of removing CPX-1 on synaptic transmission, we
recorded synaptic activity at the NMJ in dissected animals.
The worm NMJ is a graded synapse, and basal activity in the
nervous system of the dissected animal continuously drives
neurotransmitter release, as measured by whole-cell patch-
clamp recordings from body wall muscle [7]. This tonic excit-
atory postsynaptic current (tEPSC) rate depended on external
calcium, because over 90% of these fusion events were elim-
inated in zero calcium external solution (Figure S3). cpx-1
mutants display a large increase (290% of wild-type) in tEPSCrate (Figures 3A and 3C), with no change in the
tEPSC amplitude (Figure 3D). Even in low
calcium, spontaneous fusion was significantly
increased in cpx-1 mutants (Figure S3).Surprisingly, EPSCs evoked by a depolarizing stimulus elec-
trode (eEPSCs) were decreased by about 90% in cpx-1
mutants (Figures 3B and 3E), suggesting a requirement for
CPX-1 during SV fusion evoked by high levels of activity. Total
synaptic charge was decreased to a similar degree, indicating
that the eEPSC peak was not decreased simply because of
asynchrony of the evoked fusion events in the cpx-1 mutant
(data not shown). Consistent with the behavioral assays,
CPX-1 expression in GABA neurons failed to rescue either
the tEPSC rate or eEPSC, whereas expression in all neurons
rescued both modes of exocytosis. Thus, SV exocytosis is
suppressed by CPX-1 during low levels of activity, whereas
high levels of activity require CPX-1 to promote synchronous
exocytosis.
Synaptic Alterations of cpx-1 Mutants Are Not the Result
of Changes in Nervous System Development
Complexin has been proposed to play a role in synapse
development in mouse and fly [27, 35], so it is important to
examine whether the nervous system has been altered in
cpx-1 mutants. In particular, developmental changes in the
motor neurons and NMJsmay explain the behavioral and elec-
trophysiological effects described above. The number of
cholinergic motor neurons in the ventral cord was identical
between wild-type and cpx-1 mutant animals (Figure 4A).
Furthermore, we counted the number of active zones per
unit length of axon by imaging the fluorescently tagged active
zone (AZ) protein ELKS-1::CFP in wild-type and cpx-1 mutant
animals and found nearly identical AZ densities in the two
strains (Figure 4B). Thus, neither the number of motor neurons
nor the synapse number is altered appreciably in the absence
of cpx-1.
Overexpression of CPX-1 Does Not Affect the NMJ
The experiments described above establish that loss of CPX-1
at the synapse directly leads to dysregulation of tonic and
stimulus-evoked neurotransmission. If complexin functions
as a fusion clamp by binding the trans-SNARE complex, then
Figure 3. Tonic Release Increases while Evoked
Release Decreases at the NMJ in the Absence
of Complexin
(A and B) Examples of tonic (A) and evoked (B)
EPSCs for wild-type, cpx-1(ok1552), rescue in
GABA neurons, and rescue in all neurons.
(C–E) Average tonic EPSC rate (C), tEPSC ampli-
tude (D), and evoked EPSC peak (E) for each of
the four strains shown above.
See Experimental Procedures for details of
recordings. The tEPSC rate increased in cpx-1
mutants and remained elevated in the GABA
rescue transgenics. Rescue in all neurons
decreased the tonic release rate slightly below
wild-type. The evoked EPSC decreased in cpx-1
mutants, and rescue in GABA neurons failed to
restore the EPSC, whereas rescue in all neurons
restored the EPSC. Data are mean 6 SEM. #
denotes significantly different from wild-type
(p < 0.01) but not significantly different from
cpx-1. ** denotes significantly different from
cpx-1 (p < 0.01) but not significantly different
from wild-type. Significance determined by
Tukey-Kramer method.
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transmission and alter behavior by driving the formation
of excess CPX-1/trans-SNARE complexes [22, 25, 36]. We
examined the aldicarb sensitivity of cpx-1 mutant animals
expressing different amounts of a fluorescently tagged
rescuing complexin (CPX-1::pG). We found that rescue wasFigure 4. No Gross Changes in Motor Neuron Number or Synapse Density
Were Observed in cpx-1 Mutants
(A1–A3) The ventral nerve cord was imaged in animals expressing mCherry
under a cholinergic promoter in wild-type (A1) and cpx-1(ok1552) mutant
(A2) backgrounds. There was no significant difference in the number of
ventral cord motor neurons in both genotypes, as summarized in (A3).
(B1–B3) The dorsal nerve cord was imaged in animals expressing the active
zone protein ELKS-1::CFP in a subset of DA/DB motor neurons in wild-type
(B1) and cpx-1mutant (B2) backgrounds. Loss of CPX-1 did not significantly
alter the NMJ active zone density, as summarized in (B3).
Data are mean6 SEM. Number of animals analyzed is indicated within each
bar. Scale bars are 5 mm.indistinguishable over a 5-fold range of protein expression,
as measured by axonal fluorescence levels (Figures S5A and
S5D). There was also no effect on aldicarb sensitivity when
CPX-1 was overexpressed in subsets of motor neurons or in
synaptic mutants with elevated rates of transmitter release
(Figures S5B and S5C). Finally, we observed no change in
locomotory behavior in these overexpression strains (data
not shown). Thus, CPX-1 does not appear to be a limiting
factor in the regulation of synaptic transmission.
Effects of CPX-1 Domain Deletions on Behavior
Having established that overexpressing CPX-1 does not alter
aldicarb sensitivity or locomotion, we analyzed the ability of
four domain-deletion mutants and a double point mutant to
rescue the aldicarb hypersensitivity and locomotion defects
of cpx-1 mutants. The rescue constructs were fused to GFP
in order to assess relative protein expression levels in the
axon. For the strains presented here, all mutant CPX-1 variants
were expressed at the synapse with a comparable abundance
to the full-length rescue construct (Figure S5D). In agreement
with mammalian complexin studies, the central helix was
required for CPX-1 function in that its deletion (DCH)
completely eliminated rescue of both aldicarb sensitivity and
locomotion (Figure 5). A double point mutation near the end
of the central helix (K71A, Y72A) significantly decreases
SNARE binding in this highly conserved region of complexin
in both mouse and fly [25, 36]. As expected from the DCH
rescue, the KY/AA mutation eliminates rescue of aldicarb
sensitivity (Figure 5B). However, we observed a significant
recovery of locomotory function in the KY/AA mutant, sug-
gesting that some aspect of CPX-1 function persists in this
SNARE-binding mutant (Figure 5C).
Interestingly, loss of the N-terminal domain (DNTD) had no
effect on rescue, whereas loss of the C-terminal domain
(DCTD) impaired rescue in both behavioral assays (Figure 5).
Deletion of the accessory domain (DAD) impaired rescue of
aldicarb sensitivity to some extent, whereas locomotion was
Figure 5. Effects of Removing Complexin Protein Domains on Behavior
(A) Cartoon depicting the four protein domains of CPX-1: N-terminal domain
(NTD), accessory domain (AD), central helix (CH), and C-terminal domain
(CTD).
(B) Average percentage of animals paralyzed on 1.0 mM aldicarb after
40 min for wild-type (WT), cpx-1, full-length rescue CPX-1 (FL), rescue
with each of the domains individually deleted as indicated, and a double
point mutant K71A Y72A (KY/AA), all in cpx-1(ok1552). Number of aldicarb
assays for each strain is indicated either within or above the bar.
(C) Average speed for the same strains. Number of animals analyzed for
each strain is indicated within or above the bar.
Data are mean 6 SEM. # denotes significantly different from wild-type
(p < 0.01) but not significantly different from cpx-1. ** denotes significantly
different from cpx-1 (p < 0.01) but not significantly different from wild-
type. * denotes significantly different from both cpx-1 and wild-type (p <
0.01). Significance determined by Tukey-Kramer method. Details of the
domain deletions are described in the Experimental Procedures.
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of complexin as the accessory domain rather than the helix
because the C. elegans ortholog contains a proline residue
within this region (see Figure 1); thus, a purely a-helical confor-
mation would not be expected in this region of CPX-1.Effects of CPX-1 Domain Deletions on Synaptic
Transmission
We directly tested the contributions of the CH and CTD
domains to the regulation of synaptic transmission by moni-
toring SV fusion at the NMJ in these domain-deletion rescue
animals. Rescue of cpx-1 with the SNARE-binding mutant
KY/AA failed to rescue the tonic rate of fusion (Figures 6A
and 6C). Likewise, a truncated CPX-1 variant lacking its CTD
also failed to inhibit tonic neurotransmission, suggesting that
both the SNARE-binding region and the C terminus are impor-
tant for complexin’s inhibitory function (Figures 6A and 6C). In
contrast, the eEPSC was partially restored in both DCTD and
KY/AA rescue animals, indicating that these regions
contribute, but are not essential, to CPX-1 function during
stimulus-evoked SV fusion (Figures 6B and 6E). In both cases,
restoration of evoked neurotransmitter release correlated with
rescue of locomotion, demonstrating the behavioral relevance
of evoked release. In all cases, no effect on the tEPSC ampli-
tude was observed (Figure 6D). Thus, the eEPSC can be
rescued independently of the tEPSC, further supporting the
notion that complexin separately regulates these two modes
of exocytosis.
Loss of Complexin Rescues a Syntaxin Mutant
The elevated rate of tonic neurotransmission observed in
cpx-1 mutants is distinct among known synaptic mutants in
C. elegans. Two hypersecretion mutants have previously
been characterized at the worm neuromuscular junction:
slo-1 BK channel and tom-1 Tomosyn. Interestingly, evoked
SV fusion is significantly increased in both of these mutants,
whereas tonic SV fusion is relatively unaltered [37–39], further
supporting the notion that these two modes of exocytosis can
be distinguished at the molecular level. Because some SNARE
mutations that disrupt assembly of the four-helix bundle are
thought to slow the forward rate of fusion [26, 40], we
wondered whether removing complexin’s inhibitory function
would counteract a SNARE mutation and restore fusion. To
test this hypothesis, we utilized a mutant syntaxin 1 in which
a membrane-proximal conserved SNARE residue (alanine
248) is substituted with valine: unc-64 Syx(A248V) [41]. This
mutation is not in the region of syntaxin 1, which interacts
with complexin so that initial trans-SNARE assembly and com-
plexin binding would not be predicted to be altered. However,
the unc-64 Syx(A248V) nearly eliminates both tonic and stim-
ulus-evoked SV fusion, suggesting that a late stage in SNARE
assembly is impaired [39].
Intriguingly, whereas both unc-64 Syx(A248V) and cpx-1
moved at much lower speeds than wild-type animals
(17% 6 1.9% and 37% 6 2.1% of wild-type, respectively),
the cpx-1;unc-64 Syx(A248V) double mutant displayed near-
wild-type locomotion (78% 6 6.9%; Figures 7A and 7B).
Thus, loss of CPX-1 appears to restore motor system function
in the syntaxin mutant. In addition to slower locomotion,
unc-64 Syx(A248V) mutants sometimes fail to initiate move-
ment and remain quiescent throughout the locomotion assay
(17.1% 6 4% quiescent versus 2.7% 6 1.6% for wild-type;
see Figure S6A). The cpx-1;unc-64 Syx(A248V) double mutant
failed to reduce the elevated quiescence, demonstrating that
some locomotor phenotypes are not restored in the absence
of complexin.
Although it is possible that mutants with enhanced synaptic
transmissionmay generally rescue the syntaxinmutant, loss of
complexin had a significantly larger impact on the unc-64 Syx
(A248V) mutant than the hypersecretion mutants slo-1 BK
Figure 6. Central Helix-SNARE Interactions and
the C-Terminal Domain of CPX-1 Are Required
for Its Inhibition of Tonic, but Not for Evoked SV
Fusion
(A and B) Representative traces for tonic (A) and
evoked (B) EPSCs are shown for wild-type,
cpx-1(ok1552), rescue with a central helix dele-
tion (DCH), rescuewith a C-terminal domain dele-
tion (DCTD), and rescue with a double point
mutant in the central helix predicted to decrease
SNARE binding (KY/AA), all in cpx-1(ok1552).
(C–E) Average values for the frequency (C) and
amplitude (D) of tEPSCs and peak eEPSC
amplitude (E) are shown for each strain. Data
aremean6 SEM. # denotes significantly different
from wild-type (p < 0.01) but not significantly
different from cpx-1. * denotes significantly
different from both cpx-1 and wild-type (p <
0.01). Significance determined by Tukey-Kramer
method.
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is increased in eachmutant [37–39], neither could restore loco-
motion to the same extent as loss of CPX-1 (Figure 7C). Finally,
rescue of locomotion in cpx-1 might arise simply from an
impairment of SV fusion that protects a pool of vesicles from
depletion. We examined three mutants that are defective
in distinct aspects of SV exocytosis (snb-1 synaptobrevin,
unc-2Ca2+ voltage-dependent channel, and snt-1 synaptotag-
min) and found that locomotion was not significantly rescued
(Figure S6B).
We next examined the effects of removing CPX-1 in the
A248V syntaxin mutant on SV fusion. Whereas unc-64 Syx
(A248V) almost eliminated tEPSC fusion events, the cpx-1;
unc-64 Syx(A248V) double mutant displayed wild-type rates
(Figures 7D and 7F). In contrast, the eEPSC amplitude was
not restored in the cpx-1;unc-64 Syx(A248V) double mutant,
highlighting the distinct role of CPX-1 in supporting this
mode of exocytosis (Figures 7E and 7H). The average tEPSC
amplitude was decreased by about 43% in the unc-64 Syx
(A248) mutant and restored in the cpx-1;unc-64 Syx(A248V)
double mutant (Figure 7G). Although smaller tonic fusion
events might cause an apparent decrease in tEPSC frequency
if a significant number falls below detection threshold, a 43%
decrease in tEPSC amplitude is expected to cause only
a 0.2% decrease in tEPSC frequency under our recording
conditions (Figures S6C and S6D). Thus, the decrease in
tEPSC rate (and its restoration in the double mutant) repre-
sents a change in the frequency of fusion rather than a change
in tEPSC amplitude. These observations suggest that
removing CPX-1 in the unc-64 Syx(A248V) mutant can alle-
viate the defect in tonic fusion, whereas evoked EPSCs are
not restored. Furthermore, restoration of tonic neurotransmis-
sion was accompanied by an increase in locomotion, demon-
strating that this mode of exocytosis is relevant to locomotory
behavior.Discussion
The results of this study lead us to
several conclusions about the role
of complexin in C. elegans. First,
animals develop normally in the
absence of CPX-1. Second, CPX-1 has
both negative and positive functions inneurotransmission: it inhibits fusion of SVs driven by endog-
enous activity while simultaneously promoting synchronous
neurotransmitter release evoked by a strong depolarizing
stimulus. Third, the positive and negative functions can be
separated within the structure of complexin. The N-terminal
domain does not appear to play a major role in CPX-1
function, whereas the SNARE-interacting central helix is
essential for both regulatory functions of CPX-1. The C-ter-
minal domain and tight SNARE binding are required only
for complexin’s inhibitory role. Fourth, complexin’s function
in the final stages of fusion is underscored by its genetic
interactions with syntaxin. Specifically, a syntaxin ‘‘zipper-
ing’’ mutant can be rescued by removing complexin. These
data suggest that complexin bound to the trans-SNARE
complex raises the energy barrier for SV fusion. The
opposing effects of complexin removal on tonic and evoked
release suggest that these are distinct exocytic events that
can be separated at the molecular level (see model in
Figure S7A).
Separating Functions of CPX-1 Domains
N-Terminal Domain
There is evidence from murine culture studies that the NTD
facilitates evoked SV fusion and that a few residues within
the NTD are identical across several phyla (68% identity
between worm and fly), suggesting a conserved function of
this domain [24, 25]. The fly complexin NTD, however, does
not appear to affect synaptic transmission when expressed
in mouse neurons [25]. Similar to dmCplx, we observed
complete rescue of function with a version of CPX-1 missing
the entire NTD. Thus, this domain does not play a major role
in complexin function in C. elegans.
Accessory Domain
Prior studies on the AD have suggested an inhibitory role in
fusion [22, 25, 42, 43]. The nematode CPX-1 AD contains
Figure 7. Loss of CPX-1 Restores Tonic Fusion in
a Syntaxin 1 Mutant
(A) Representative locomotion trajectories for
a hypomorphic allele of syntaxin 1 unc-64(e246)
corresponding to A248V, as well as cpx-1 and
the cpx-1 syntaxin(A248V) double mutant (cpx-1;
unc-64).
(B) Summary of average speed for wild-type (WT)
animals, in addition to the three strains described
above.
(C) Summary of average speed for syntaxin
1(A238V) unc-64 mutants and three double
mutants in which unc-64 is paired with cpx-1
(cpx-1;unc-64), slo-1 BK channel (slo-1;unc-64),
and tom-1 Tomosyn (tom-1;unc-64). Number of
animals analyzed for each strain is indicated
within the bar. ## denotes significantly different
from unc-64 (p < 0.01).
(D–H) Representative traces for tonic (D) and
evoked (E) EPSCs are shown for all four
strains. Average values for the frequency (F)
and amplitude (G) of tEPSCs and peak eEPSC
amplitude (H) are shown for each strain. Data
are mean 6 SEM. # denotes significantly
different from wild-type (p < 0.01) but not signifi-
cantly different from cpx-1. ** denotes signifi-
cantly different from cpx-1 (p < 0.01) but not
significantly different from wild-type. * denotes
significantly different from both cpx-1 and wild-
type (p < 0.01). Significance determined by
Tukey-Kramer method.
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structure. Regardless, aldicarb sensitivity cannot be fully
rescued in the absence of this domain, so this region contrib-
utes to the suppression of ACh release, in agreement with fly
and mouse complexin.
Central Helix
The physical interaction of complexin with the SNARE
complex is mediated by residues of the CH and residues lining
the groove between syntaxin and synaptobrevin. The CH-
deleted CPX-1 failed to rescue in all of our behavioral and elec-
trophysiological assays, suggesting an essential requirement
for complexin function in the worm, a conclusion that holds
for all studies of complexin function. SNARE binding is
reduced by mutating two key residues (K71A Y72A) [22, 36].
This mutation eliminated the facilitatory and inhibitory func-
tions of mouse Cplx1, as well as the inhibitory function of fly
dmCplx in mouse cultured neurons [22, 25, 26]. In contrast,
we found that the defective CPX-1(KY/AA) can still support
evoked fusion to a significant degree at the C. elegans NMJ,
suggesting that tight SNARE binding is not essential for
promoting neurotransmission.
C-Terminal Domain
Little is known about the structure or function of the C-terminal
domain of complexin. An in vitro study suggests that this
region of complexin contributes to its function by binding to
membranes and stimulating liposome fusion [44]. However,
inmouse autaptic cultures, a truncatedCplx1missing its entireCTD was able to rescue synaptic trans-
mission in the Cplx1/2 double knockout
[22]. In contrast, the fly dmCplx CTD is
required for suppression of sponta-
neous and evoked SV fusion at the fly
NMJ [28] and in mouse autaptic cultures
[25]. We find that without its CTD, CPX-1can no longer suppress tonic release, establishing a require-
ment for the CTD in the fusion clamp activity of complexin. In
contrast to tonic release, the CTD deletion mutant retains
50% normal evoked responses, demonstrating that this
domain is not essential for the facilitation of evoked SV fusion
by complexin.
A Distinct Role of Complexin during Stimulus-Evoked
Release
Decreased evoked release has been observed in mouse
[14, 22, 26], fly [27], and worm (this study) synapses lacking
complexin. This deficit could have simply reflected the deple-
tion of a readily releasable pool of SVs in the wake of an
elevated spontaneous fusion rate. Indeed, Hobson et al. (this
issue of Current Biology) report a substantial decrease in SV
number in cpx-1 mutant worms, suggesting that vesicle pool
depletion contributes to this defect in exocytosis [45].
However, our data reveal a separate role for complexin in sup-
porting evoked fusion. We show here that evoked release can
be restored to a significant degree even when tonic release
remains elevated (KY/AA and CTD deletion rescue). The
central helix is required for rescue of evoked release, indi-
cating that the central helix has additional functions during
evoked fusion. Perhaps complexin interacts with another
target at the synapse to promote fusion when calcium levels
are elevated. Further studies will be needed to address this
possibility.
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of Synaptic Transmission
By demonstrating opposing roles for complexin in the control
of tonic release versus evoked responses, we have shown that
both forms of synaptic transmission are distinct and differen-
tially regulated. If the level of synaptic activity determines
whether complexin will inhibit or support SV fusion, complexin
can serve as a temporal filter, suppressing low frequency
activity while boosting higher frequencies (Figure S7B). The
tonic and phasic outputs seem to play different roles in the
regulation of behavior. Tonic release in the absence of evoked
release is sufficient for basal locomotory speed but not normal
levels of foraging behavior. Thus, complexin can act as
a master switch for temporal coding mechanisms at the
synapse, gating the balance of tonic and phasic output.
Experimental Procedures
Details of the behavioral assays, electrophysiology, and fluorescence
imaging, as well as a list of all strains used in this study, can be found in
the Supplemental Experimental Procedures.
Complexin Mutants and Rescue Constructs
C. elegans full-length complexin CPX-1 is 143 amino acids encoded by a
1.2 kb gene harboring a single 764 base intron. For the structural variants
of CPX-1 used in this study, we used the following residue positions to
define each domain. The first 30 amino acids are removed in the N-terminal
deletion CPX. Residues 31–50 are removed in the accessory domain
deletion. The central helix deletion corresponds to residues 51–79. The
C-terminal domain deletion removes the final 50 residues of CPX-1 and
includes a 12 residue linker between CPX-1 and paGFP.
Statistical Analysis
For data sets requiring a single pairwise comparison, we used Student’s t
test to compute significance. For all other comparisons, we used the Tukey-
Kramer method for multiple comparisons. This test assumes independent,
normal distributions with equal variance. In cases in which sample variance
was significantly different (calculated using Levene’s test), we employed the
Newman-Keulsmethod to test significance. Significancewas defined by the
criterion p < 0.01.
Supplemental Information
Supplemental Information includes seven figures and Supplemental Exper-
imental Procedures and can be found with this article online at doi:10.1016/
j.cub.2010.12.014.
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